(Q37738515)

22 August 2017

1 reference

title

Iron overload in patients with myelodysplastic syndromes (English)

1 reference

22 August 2017

1 reference

Peter-D Jensen

1

1 reference

22 August 2017

language of work or name

1 reference

1 February 2007

1 reference

Current hematologic malignancy reports

22 August 2017

published in

1 reference

22 August 2017

volume

2

1 reference

22 August 2017

issue

1

1 reference

22 August 2017

page(s)

13-21

1 reference

Proposals for the classification of the myelodysplastic syndromes

22 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11899-007-0003-5

Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11899-007-0003-5

Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia

21 January 2018

1 reference

12 December 2020

Labile plasma iron in iron overload: redox activity and susceptibility to chelation

1 reference

12 December 2020

Liver iron concentration, stainable iron, and total body storage iron

1 reference

12 December 2020

Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone

1 reference

12 December 2020

ICL670A: preclinical profile.

1 reference

12 December 2020

The effect of erythroid hyperplasia on iron balance

1 reference

12 December 2020

Labile plasma iron (LPI) as an indicator of chelatable plasma redox activity in iron-overloaded beta-thalassemia/HbE patients treated with an oral chelator

1 reference

12 December 2020

Evaluation of transfusional iron overload before and during iron chelation by magnetic resonance imaging of the liver and determination of serum ferritin in adult non-thalassaemic patients

1 reference

12 December 2020

Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major

1 reference

12 December 2020

Non-transferrin-bound iron in myelodysplastic syndromes: a marker of ineffective erythropoiesis?

1 reference

12 December 2020

Long-term treatment of transfusional iron overload with the oral iron chelator deferiprone (L1): a Dutch multicenter trial.

1 reference

12 December 2020

Natural history of idiopathic refractory sideroblastic anemia

1 reference

12 December 2020

Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool.

1 reference

12 December 2020

Serum ferritin in patients with iron overload and with acute and chronic liver diseases

1 reference

12 December 2020

Iron-chelating therapy with the new oral agent ICL670 (Exjade).

1 reference

12 December 2020

Needle liver biopsy in thalassaemia: analyses of diagnostic accuracy and safety in 1184 consecutive biopsies

1 reference

12 December 2020

Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients

1 reference

12 December 2020

Survival in medically treated patients with homozygous beta-thalassemia

1 reference

12 December 2020

Assessment of liver iron content in 271 patients: a reevaluation of direct and indirect methods

1 reference

12 December 2020

The effect of iron chelation on haemopoiesis in MDS patients with transfusional iron overload

1 reference

12 December 2020

Uptake of non-transferrin-bound iron by both reductive and nonreductive processes is modulated by intracellular iron

1 reference

12 December 2020

Hepatic iron concentration and total body iron stores in thalassemia major.

1 reference

12 December 2020

An alternative to continuous subcutaneous infusion of desferrioxamine in thalassaemic patients

1 reference

12 December 2020

Proton transverse relaxation rate (R2) images of liver tissue; mapping local tissue iron concentrations with MRI [corrected]

1 reference

12 December 2020

Indirect evidence for the potential ability of magnetic resonance imaging to evaluate the myocardial iron content in patients with transfusional iron overload

1 reference

12 December 2020

Secretion of ferritin by rat hepatoma cells and its regulation by inflammatory cytokines and iron.

1 reference

12 December 2020

Relapsing sideroblastic anaemia

1 reference

12 December 2020

Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia

1 reference

12 December 2020

MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients

1 reference

12 December 2020

Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major.

1 reference

12 December 2020

Relationship between hepatocellular injury and transfusional iron overload prior to and during iron chelation with desferrioxamine: a study in adult patients with acquired anemias

1 reference

12 December 2020

Safety and efficacy of subcutaneous bolus injection of deferoxamine in adult patients with iron overload

1 reference

12 December 2020

Combined therapy with deferiprone and desferrioxamine

1 reference

12 December 2020

Long-term efficacy of deferoxamine iron chelation therapy in adults with acquired transfusional iron overload

1 reference

12 December 2020

Secondary hemochromatosis in polytransfused patients with myelodysplastic syndromes

1 reference

12 December 2020

A patient-oriented approach to treatment of myelodysplastic syndromes.

1 reference

12 December 2020

Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major

1 reference

12 December 2020

Iron metabolism in inflammation

1 reference

12 December 2020

Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance.

1 reference

12 December 2020

Iron-chelating therapy and the treatment of thalassemia.

1 reference

12 December 2020

Clinical consequences of acquired transfusional iron overload in adults

1 reference

12 December 2020

Pathophysiology of iron overload.

1 reference

12 December 2020

Liver iron stores in patients with secondary haemosiderosis under iron chelation therapy with deferoxamine or deferiprone

1 reference

12 December 2020

Mechanism of Desferrioxamine-Induced Iron Excretion in Thalassaemia

1 reference

12 December 2020

Subcutaneous bolus injection of deferoxamine in adult patients affected by onco-hematologic diseases and iron overload

1 reference

12 December 2020

Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major

1 reference

12 December 2020

LATE CARDIAC COMPLICATIONS OF CHRONIC, SEVERE, REFRACTORY ANEMIA WITH HEMOCHROMATOSIS

1 reference

12 December 2020

Noninvasive measurement of iron: report of an NIDDK workshop

1 reference

12 December 2020

Insulin dependent diabetes in thalassaemia

1 reference

12 December 2020

Measurement of iron status

1 reference

12 December 2020

Non-invasive assessment of tissue iron overload in the liver by magnetic resonance imaging

1 reference

12 December 2020

Effect of age at the start of iron chelation therapy on gonadal function in beta-thalassemia major

1 reference

12 December 2020

Heart cells in culture: a model of myocardial iron overload and chelation.

1 reference

12 December 2020

Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial

1 reference

12 December 2020

Depletion of excessive liver iron stores with desferrioxamine

1 reference

12 December 2020

Sustained normalization of cardiac function by chelation therapy in thalassaemia major

1 reference

12 December 2020

Iron chelators for thalassaemia

1 reference

12 December 2020

Role of deferiprone in chelation therapy for transfusional iron overload

1 reference

12 December 2020

10.1007/S11899-007-0003-5

Identifiers

DOI

1 reference

22 August 2017

1 reference